CEO’s: Share your company’s growth story with Wall Street Reporter’s global investor audience. Our new “Express” format is fully automated, and you can do this interview anytime, right from your computer or smart phone. CLICK […]
Oragin Foods (OTC: OGGFF) (TSX: OG) Unleashes 30X Upside Potential! Organic Garage (OTC: OGGFF) (TSX: OG) Explosive Growth Potential ’22 Outlook Next Super Stock 1/14/2022 livestream Organic Garage (OTC: OGGFF) (TSX: OG) Plant-Based Foods Booming! Next […]
Enthusiast Gaming Holdings Inc. (NASDAQ: ENGMF) Q4 2020 Earnings Highlights “…Enthusiastic Gaming is the home for Gen Z and millennial video game and esports fans. We build communities for these fans that are powered by […]
“Scaling & Exponential Revenue Growth” NexTech AR (OTC: NEXCF) (CSE: NTAR) CEO Live Chat October 9, 2020 NEXT SUPER STOCK – July 23, 2020 Livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s […]
“Scaling & Exponential Revenue Growth” NexTech AR (OTC: NEXCF) (CSE: NTAR) CEO Live Chat September 17 NEXT SUPER STOCK – July 23, 2020 Livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship […]
NexTech AR (OTC: NEXCF) August 21, NEXT SUPER STOCK livestream NEXT SUPER STOCK – July 23, 2020 Livestream Wall Street Reporter’s NEXT SUPER STOCK NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) livestream conference presentation July […]
Both companies are working together to create many new and exciting AR business use cases NEW YORK and TORONTO, May 26, May 26, 2020 (GLOBE NEWSWIRE via COMTEX) — NexTech AR Solutions (the “Company” or […]
FDA has approved 54 Emergency INDs to allow access to leronlimab for severely and critically ill COVID-19 patients VANCOUVER, Washington and WINSTON-SALEM, May 07, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a […]
VANCOUVER, Washington, April 15, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]
Numerous complaints about fraudulent billing practices have been emerging from Regus offices. It appears the company is desperate for cash. Story developing…
VANCOUVER, Washington, Feb 12, 2020 (GLOBE NEWSWIRE via COMTEX) — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, […]
NEXT SUPER STOCK conference presenter, Nightfood Holdings, Inc. (OTC: NGTF), Interview with CEO Sean Folkson. Since our last interview in June, NGTF has made significant progress. In […]
September 26, 2019 conference presenters: Hoth Therapeutics, Inc. (NASDAQ: HOTH) CEO Robb Knie, shares the latest updates on Hoth’s pipeline of targeted dermatological therapies, which address multi-billion dollar market opportunities, including: eczema, psoriasis, chronic wound […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
